Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma ; volume:3 ; number:1 ; day:19 ; month:5 ; year:2015 ; pages:1-11 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (19.5.2015), 1-11, 12.2015
- Creator
-
Lussier, Danielle M.
- Contributor
-
Johnson, John L.
Hingorani, Pooja
Blattman, Joseph N.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-015-0067-z
- URN
-
urn:nbn:de:1111-201610306371
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lussier, Danielle M.
- Johnson, John L.
- Hingorani, Pooja
- Blattman, Joseph N.
- SpringerLink (Online service)
Other Objects (12)
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Granulosa Cell‐Layer Stiffening Prevents Escape of Mural Granulosa Cells from the Post‐Ovulatory Follicle
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma
GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Granulosa Cell‐Layer Stiffening Prevents Escape of Mural Granulosa Cells from the Post‐Ovulatory Follicle
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma
GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Granulosa Cell‐Layer Stiffening Prevents Escape of Mural Granulosa Cells from the Post‐Ovulatory Follicle
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma